8 July 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
10 July 2025 - NICE has published final evidence-based recommendations on the use of zanubrutinib for the treatment of adults ...
9 July 2025 - Donald Trump’s move to ramp up tariffs on medicines and copper has sparked alarm among government ...
9 July 2025 - The threat of global 200 per cent tariffs on pharmaceutical products presents a challenge to Australia’s drug ...
5 July 2025 - A new twice yearly antiviral injection that can prevent HIV is likely to be approved soon in ...
2 July 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
3 July 2025 - Pluvicto now publicly funded in provinces covering most Canadians, offering renewed hope to those facing progressive PSMA ...
2 July 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
4 July 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the March 2025 ...
1 July 2025 - We’re improving our processes, so that people can understand the outcome of expert advice to PHARMAC earlier. ...
3 July 2025 - Pharma giants are sweating on the results of a federal government request for guidance on adding weight ...
3 July 2025 - American pharmaceutical manufacturers have ramped up pressure on Donald Trump to take action against Australia over its ...
2 July 2025 - A key treatment which could help around one million middle-aged Australian women remains unaffordable to many ...
1 July 2025 - A potentially life-saving treatment for early-stage breast cancer will become much more affordable for hundreds of ...
2 July 2025 - NICE is unable to make a recommendation on the use of adagrasib (Krazati) for the second-line treatment ...